Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-ART-3732
Vaccine 2004 Apr 16;2213-14:1810-9. doi: 10.1016/j.vaccine.2003.10.052.
Show Gene links Show Anatomy links

Reverse transcriptase-based DNA vaccines against drug-resistant HIV-1 tested in a mouse model.

Isaguliants MG , Zuber B , Boberg A , Sjöstrand D , Belikov SV , Rollman E , Zuber AK , Rechinsky VO , Rytting AS , Källander CF , Hinkula J , Kochetkov SN , Liu M , Wahren B .


???displayArticle.abstract???
Drug resistance is becoming a problem in the treatment of the human immunodeficiency virus type one (HIV-1). To obtain therapeutic DNA vaccines that would target multiple drug-resistance (DR) mutations, we cloned genes for DR HIV-1 reverse transcriptase (RT) and codon-optimized synthetic genes encoding clusters of human CTL epitopes located at the sites of DR-mutations (RT minigenes) and antibody and CTL-epitope tags. Expression of RT genes/minigenes in eukaryotic cells was confirmed by Western blotting and immunofluoresence staining with RT- or tag-specific antibodies. Immunization of mice with DR-RT gene induced no RT-specific antibodies. Immunization of HLA-A(*)0201-transgenic mice with RT minigenes induced RT-specific cellular responses detected by interferon-gamma secretion. This documents first steps in creating therapeutic vaccine against drug-resistant HIV strains.

???displayArticle.pubmedLink??? 15068865
???displayArticle.link??? Vaccine


Species referenced: Xenopus laevis
Genes referenced: mhc1-uaa
GO keywords: reverse transcription

???displayArticle.disOnts??? human immunodeficiency virus infectious disease